AI At The Crossroads Of Regulation And Innovation

AI is beginning to transform life sciences manufacturing, but bringing intelligent systems into regulated environments introduces new challenges around validation, governance, and trust. This episode of Augmented Ops features a grounded discussion between Michelle Vuolo, Bryan Ennis, and Martin Heitmann on what it truly takes to deploy AI responsibly across pharma, biotech, and medtech operations. They break down why so many projects stall at the pilot stage, how traditional validation frameworks must adapt for probabilistic models, and where organizations are already realizing meaningful value—from predictive maintenance to quality signal detection and automated validation workflows. Tune in to explore practical pathways to trustworthy AI in manufacturing.